Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.
This report contains market size and forecasts of Nuclear Medicine & Radiopharmaceuticals in global, including the following market information:
Global Nuclear Medicine & Radiopharmaceuticals Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Nuclear Medicine & Radiopharmaceuticals Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Nuclear Medicine & Radiopharmaceuticals companies in 2021 (%)
The global Nuclear Medicine & Radiopharmaceuticals market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Diagnostic Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nuclear Medicine & Radiopharmaceuticals include China Isotope & Radiation, Dongcheng, Jaco, Ciaeriar, Advanced Molecular-imaging Solution and Shanghai Atom Kexing, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nuclear Medicine & Radiopharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nuclear Medicine & Radiopharmaceuticals Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nuclear Medicine & Radiopharmaceuticals Market Segment Percentages, by Type, 2021 (%)
Diagnostic
Therapeutic
Global Nuclear Medicine & Radiopharmaceuticals Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nuclear Medicine & Radiopharmaceuticals Market Segment Percentages, by Application, 2021 (%)
Oncology
Thyroid
Cardiology
Others
Global Nuclear Medicine & Radiopharmaceuticals Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nuclear Medicine & Radiopharmaceuticals Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nuclear Medicine & Radiopharmaceuticals revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Nuclear Medicine & Radiopharmaceuticals revenues share in global market, 2021 (%)
Key companies Nuclear Medicine & Radiopharmaceuticals sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Nuclear Medicine & Radiopharmaceuticals sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
China Isotope & Radiation
Dongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing